Friday, July 10, 2026

Drug profile · INN

arimoclomol

arimoclomol (MIPLYFFA) is an FDA-listed pharmaceutical active ingredient.

EMA: application withdrawn Nervous system (N07) N07
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — arimoclomol
Class
Nervous system (N07)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

arimoclomol (MIPLYFFA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN arimoclomol
Brand MIPLYFFA
Therapeutic class Nervous system (N07)
ATC code N07

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. brivaracetam Nervous system (N03)
  4. bupivacaine Nervous system (N01)
  5. buprenorphine Nervous system (N07)
  6. caffeine citrate Nervous system (N06)

Frequently asked questions

What is arimoclomol?

arimoclomol (MIPLYFFA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for arimoclomol?

MIPLYFFA is a marketed brand name for arimoclomol. Check FDA Drugs@FDA for the current US label holder and prescribing information.